Zentiva and Lupin Sign License and Supply Agreement for TNF alpha inhibitor biosimilar medicine

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

ZENTIVA-Lupin-agmt

More Like This

PR Newswire associated0

Zentiva joins the Critical Medicines Alliance to enhance EU Medicine Supply

PR Newswire associated0

Zentiva secures approx. 85.27% of APONTIS PHARMA AG voting rights in the context of its public purchase offer

PR Newswire associated0

Zentiva and Euractiv Bring Policymakers Together for Health Policy Conference

PR Newswire associated0

Zentiva Joins the Call to Action to Finalize Pharmaceutical Reform and Secure Sustainable Healthcare for People in Europe

PR Newswire associated0

Zentiva completes voluntary public purchase offer for APONTIS PHARMA AG

PR Newswire associated0

Zentiva calls for Pause - Repair - Relaunch of the Urban Wastewater Treatment Directive (UWWTD)

PR Newswire associated0

Zentiva hosted the "European Health Check":

PR Newswire associated0

Prestige Biopharma's Herceptin Biosimilar Tuznue® Receives Positive CHMP Opinion from the EMA